Evidence map›Paper›PMID 25616962›Full record

ArticleHuman molecular genetics2015

FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.

Matthew R Karolak, Xiangli Yang, Florent Elefteriou

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. FGF/FGFR signaling in health and disease.Signal transduction and targeted therapy · 2020
    Review
  10. Emerging therapeutic targets for neurofibromatosis type 1.Expert opinion on therapeutic targets · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matthew R KarolakDepartment of Pharmacology, Vanderbilt Center for Bone Biology.
Xiangli YangDepartment of Pharmacology, Vanderbilt Center for Bone Biology, Department of Medicine and.
Florent ElefteriouDepartment of Pharmacology, Vanderbilt Center for Bone Biology, Department of Medicine and Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA florent.elefteriou@vanderbilt.edu.
Vanderbilt University Medical Center · US

Funding

TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
ATF4 in Chondrocytes Regulates Cartilage to Bone TransitionR01AR067303 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI YANG, XIANGLI · 2015 to 2020
$1.7M
Bone Pseudoarthrosis Dissected through the Generation of New Mouse ModelsR01AR055966 · NIAMS · VANDERBILT UNIVERSITY · PI ELEFTERIOU, FLORENT · 2009 to 2013
$1.7M
ATF4 is Downstream Effector of Bone Anabolic Growth FactorsR03DE017111 · NIDCR · VANDERBILT UNIVERSITY · PI YANG, XIANGLI · 2006 to 2007
$147k
NIAMS NIH HHS 5R01AR055966-05NIDCR NIH HHS R03 DE017111NIGMS NIH HHS 5T32GM007628-37
6 · The paper itself

Abstract

Aberrant fibroblast growth factor receptor 3 (FGFR3) signaling disrupts chondrocyte proliferation and growth plate size and architecture, leading to various chondrodysplasias or bone overgrowth. These observations suggest that the duration, intensity and cellular context of FGFR signaling during growth plate chondrocyte maturation require tight, regulated control for proper bone elongation. However, the machinery fine-tuning FGFR signaling in chondrocytes is incompletely defined. We report here that neurofibromin, a Ras-GAP encoded by Nf1, has an overlapping expression pattern with FGFR1 and FGFR3 in prehypertrophic chondrocytes, and with FGFR1 in hypertrophic chondrocytes during endochondral ossification. Based on previous evidence that neurofibromin inhibits Ras-ERK signaling in chondrocytes and phenotypic analogies between mice with constitutive FGFR1 activation and Nf1 deficiency in Col2a1-positive chondrocytes, we asked whether neurofibromin is required to control FGFR1-Ras-ERK signaling in maturing chondrocytes in vivo. Genetic Nf1 ablation in Fgfr1-deficient chondrocytes reactivated Ras-ERK1/2 signaling in hypertrophic chondrocytes and reversed the expansion of the hypertrophic zone observed in mice lacking Fgfr1 in Col2a1-positive chondrocytes. Histomorphometric and gene expression analyses suggested that neurofibromin, by inhibiting Rankl expression, attenuates pro-osteoclastogenic FGFR1 signaling in hypertrophic chondrocytes. We also provide evidence suggesting that neurofibromin in prehypertrophic chondrocytes, downstream of FGFRs and via an indirect mechanism, is required for normal extension and organization of proliferative columns. Collectively, this study indicates that FGFR signaling provides an important input into the Ras-Raf-MEK-ERK1/2 signaling axis in chondrocytes, and that this input is differentially regulated during chondrocyte maturation by a complex intracellular machinery, of which neurofibromin is a critical component.

Indexed as

OsteogenesisSignal TransductionAnimalsChondrocytesChondrogenesisCollagen Type IIFemaleGene ExpressionGene Knockout TechniquesGrowth PlateHypertrophyMaleMiceMice, KnockoutNeurofibromin 1OsteoclastsCol2a1 protein, mouseCollagen Type IIinfigratinibNeurofibromin 1Phenylurea CompoundsPyrimidinesReceptor, Fibroblast Growth Factor, Type 1Receptor, Fibroblast Growth Factor, Type 3

Identifiers

PMID25616962
PMCPMC4383864
OpenAlexW2150686415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.